Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $119.00
otakuyassine3@gmail.com Blueprint Medicines (NASDAQ:BPMC – Free Report) had its target price boosted by Piper Sandler from...
NASDAQ:BPMC
Blueprint Medicines’ (BPMC) Outperform Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in...